Loading clinical trials...
Loading clinical trials...
Fibrinogen in Liver Transplant Subjects (FITS)
Conditions
Interventions
Intercept Fibrinogen Complex (IFC)
Cryoprecipitate Antihemophilic Factor (AHF)
Locations
1
United States
University of Cincinnati
Cincinnati, Ohio, United States
Start Date
January 1, 2026
Primary Completion Date
March 1, 2028
Completion Date
March 1, 2028
Last Updated
December 5, 2025
NCT07063940
NCT05216991
NCT06916325
Lead Sponsor
Trauma Hemostatis and Oxygenation Research (THOR) Network
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions